Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study. - Lebwohl MG; Koo JY; Jaworski J; Trefler J; Daniluk S; Dudek A; Baran W; Owczarek W; Kolinek J; Brzewski P; Sikora M; Krogulec M; et al. (Advances in therapy, 2025)